| Product Candidate |
Indication |
Development Status |
Information |
| 99mTc-glucarate products |
| AMISCAN |
Myocardial Ischemia |
Phase II |
information |
| BTSCAN |
Breast Cancer Imaging |
Phase II |
information |
| Fusion Protein Vaccine Technology |
| Anthrax Vaccine |
Anthrax prophylaxis |
Preclinical |
information |
| Botulinum Toxin Vaccine |
Botulinum prophylaxis |
Preclinical |
information |
| Monoclonal Antibodies |
| Human Anti-Rabies Mab |
Rabies post-exposure treatment |
Phase l |
information |
| New Imaging Products |
| Zn-DPA - B |
Breast (Diagnostic/Therapeutic) |
Preclinical |
|
| Zn-DPA - G |
Glioma (Diagnostic/Therapeutic) |
Preclinical |
|
| Zn-DPA - I |
Bacterial Infections |
Preclinical |
|
| Zn-DPA - H |
Heart Ischemia |
Preclinical |
|
| Zn-DPA - P |
Prostate (Diagnostic/Therapeutic) |
Preclinical |
|
| SapC-DOPS |
Tumor Imaging |
Preclinical |
|
| Cu64-CNND1-B |
Breast Cancer (Diagnostic/Therapeutic) |
Preclinical |
|
| Cu64-CNND1-L |
Lung Cancer (Diagnostic/Therapeutic) |
Preclinical |
|
Pipeline